ATRC
AtriCure, Inc.
Next earnings Jul 27, 2026 (after close) · consensus $0.01 EPS, $155M rev
Last earnings +2.1% on 2026-05-05
$28.13
▼ -0.53%$28.13▼ -10.41%
over 1Y
L $25.86EODHDH $42.41
Earnings Dividend Split Congress buy Congress sellGrouped by date · hover a pin to expand
Today-0.5%
1W-2.3%
1M-2.4%
3M-6.4%
YTD-28.4%
1Y-10.4%
Sell
Conviction
Horizon
Medium (3–12mo)
Street · 16 analysts
Buy
Revenue grew 14.9% YoY; but unprofitable (net margin -2.1%).
AtriCure, Inc. shows $535M in FY2025 revenue (+14.9% YoY), a -2.1% net margin, and -2.3% ROE.
Sources: SEC EDGAR (CIK 0001323885, latest 10-Q filed 2026-05-06) · EODHD · as of 6/26/2026, 1:53:15 AM.
Research and education only — not financial advice. EDGAR is not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities EDGAR rates; see Disclosures. Past performance does not guarantee future results. Do your own research.